Sign in

Keurig Dr Pepper Inc. KDP

Price 32.6 USD
as of 2026-09-03
49/100
No view
Quality52
Growth63
Balance-sheet strength16
Valuation52
Momentum60
Income70

Composite 49/100; the shares have moved about 28% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 16/100 — a strong mark against it.

Case for

Income ranks 70/100 — a moderate point in its favour. Growth ranks 63/100 — a moderate point in its favour. Momentum ranks 60/100 — a slight point in its favour.

Case against

Balance-sheet strength ranks 16/100 — a strong mark against it.

What the company does Keurig Dr Pepper Inc. (KDP) manufactures and distributes non-alcoholic beverages and single-serve brewing systems across three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. Its portfolio includes 125+ brands such as Dr Pepper, Snapple, Green Mountain Coffee, Bai, and Starbucks at-home offerings.

Key financials KDP’s trailing twelve-month (TTM) margins: gross 51%, operating 12.9%, net 7.1%. Revenue grew 8.2% while EPS rose 44.9%. ROE is 5.1% and ROA is 3.4%. Debt/Equity is 1.00 with net debt/EBITDA at 6.66; dividend yield is 2.8% with a 43.8% payout.

Stock health Sidera’s overall score is 48.2 (Weak quality, fairly valued). Quality 52.1, Growth 65.8, Strength 16.8, Valuation 53.1, Momentum 52.1, Income 70.9. Piotroski F-Score is 7/9; current ratio is 0.48.

Price vs fair value KDP trades at a **discount of 9.80%** versus the analyst mean target of 35.71. - Can Keurig Dr Pepper's Energy Growth Offset Coffee Market Softness? (Zacks) - Etsy upgraded, TJX downgraded: Wall Street's top analyst calls (The Fly)

Looking forward Forward P/E is 12.74 and PEG is 0.09, suggesting earnings growth may not be fully priced. EV/EBITDA stands at 17.15. Recent momentum is positive over 3m (12.44%) and 6m (10.95%), but negative over 12m (-4.53%).

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.